IOL Chemicals and Pharmaceuticals Limited

Equities

IOLCP

INE485C01011

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:47 2024-04-18 am EDT 5-day change 1st Jan Change
389.2 INR -0.54% Intraday chart for IOL Chemicals and Pharmaceuticals Limited -2.47% -15.98%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units MT
IOL Chemicals Gets Nod to Export Diabetes Drug to China MT
IOL Chemicals and Pharmaceuticals Limited Announces CDE, China Approved Metformin Hydrochloride CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 08, 2024
IOL Chemicals and Pharmaceuticals Limited Approves Closing of M/S Iol Global Limited, Uk, Wholly Owned Subsidiary of the Company CI
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Financial Year 2023-24 CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q2 2024 Earnings Call, Nov 09, 2023
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q1 2024 Earnings Call, Aug 16, 2023
CARE Keeps A+ Rating on IOL Chemicals' Long-term Bank Financing; Outlook Stable MT
IOL Chemicals Opens New Acetic Anhydride Facility MT
IOL Chemicals Granted New Patent in India MT
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q4 2023 Earnings Call, May 09, 2023
IOL Chemicals Gets European Drug Regulator's Approval to Export Paracetamol MT
IOL Chemicals and Pharmaceuticals Receives Cep for Paracetamol to Export in European Market CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
IOL Chemicals Appoints CEO MT
IOL Chemicals and Pharmaceuticals Appoints Vikas Vij as CEO CI
IOL Chemicals and Pharmaceuticals Limited Announces Resignation of Sanjay Chaturvedi as CEO CI
Transcript : IOL Chemicals and Pharmaceuticals Limited, Q3 2023 Earnings Call, Feb 09, 2023
IOL Chemicals and Pharmaceuticals Limited Declares Interim Dividend for the Fiscal Year 2023, Payable Before 8 March 2023 CI
IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
IOL Chemicals & Pharmaceuticals Forms New Unit in UK MT
Chart IOL Chemicals and Pharmaceuticals Limited
More charts
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical, and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) include Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin. Its Specialty Chemical division includes Ethyl Acetate, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and paint industry.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
391.3 INR
Average target price
517 INR
Spread / Average Target
+32.12%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IOLCP Stock
  4. News IOL Chemicals and Pharmaceuticals Limited
  5. CARE Affirms A+ Rating on IOL Chemicals' Long-term Bank Financing; Outlook Stable